Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Tundra lists 1 Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06649292

SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

The study evaluated the overall survival (OS) of SHR-A1904 versus investigator-selected treatment in second-line CLDN18.2-positive advanced GC/GEJC patients

Gender: All

Ages: 18 Years - 75 Years

Updated: 2024-12-12

1 state

Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma